Indications
Cardiac arrest (VF, pulseless VT, asystole, PEA). Newborn whose heart rate stays under 60 despite ventilation and chest compressions.
Contraindications
Hypersensitivity, cardiac dilatation, coronary insufficiency.
Adult dose
Cardiac arrest: 1 mg IV/IO during the first or second round of compressions. Give it early for non-shockable rhythms. Repeat every 3 to 5 minutes (2025 AHA).
Pediatric dose
Newborn with heart rate under 60 despite effective ventilation and chest compressions: 0.01 mg/kg of 0.1 mg/mL IV/IO, q 3-5 min while heart rate stays under 60
Child in cardiac arrest: follow local protocol. The national guideline's printed dose for this does not match its newborn dose, so it is left off this card.
Route
IV, IO
Special considerations
Compressions and defibrillation matter most, so get your IV or IO access without stopping compressions. For IO in arrest, the proximal humerus is preferred in adults and the tibia in infants and children. It works through strong alpha effects (vasoconstriction) plus beta-1 effects. In severe hypothermia, guidance differs: some guidelines withhold drugs until core temperature is above 30°C (86°F), then double the dosing interval until 35°C (95°F).
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Cardiac Arrest (VF/VT/Asystole/PEA); Neonatal Resuscitation; Hypothermia/Cold Exposure. AHA Guidelines for CPR and ECC, Adult Advanced Life Support (2025): Vasopressor Management in Cardiac Arrest. Levels from the National EMS Scope of Practice Model (2019).